“The darkest hour is just before the dawn,” says Rupert Thompson of Kingswood. British shares shrugged off this week’s new lockdown, with the FTSE 100 gaining almost 2% in the first two days of the year. The short-term news is dire, but investors are concentrating on the vaccine rollout, which should pave the way for a return to normal. Provided the vaccination campaign continues without any serious glitches then traders will remain bullish.
The Brexit deal was met with relief. With no-deal uncertainty finally out of the way another key headwind has been removed for UK shares. The index has plenty of room to rise after turning in an abysmal performance last year, falling by 14.3% for its worst showing since 2008. The FTSE 100 has underperformed for some time, notes Stefan Wagstyl in the Financial Times. Since 2016 it has gained less than 8%, compared with a 44% rise in German markets. British shares finally picked up in October, with the FTSE 250 up by 22% since then. That isn’t just vaccine euphoria. It also reflects hope that with the post-Brexit outlook clearer business investment will soar.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Revolut launches its first stocks and shares ISA with BlackRock and Vanguard ETFsA year after getting its UK banking licence, Revolut is now launching its first stocks and shares ISA with a suite of exchange-traded funds (ETFs) from BlackRock and Vanguard.
-
What does Trump’s ‘Big Beautiful Bill’ mean for the US economy?Donald Trump’s budget bill will slash taxes, but is expected to add at least $3 trillion to US national debt
-
AJ Bell: a fine British fintech going cheapOpinion Don’t overlook investment platform AJ Bell, a significantly undervalued British business with an excellent financial base
-
Aim has missed its target – will it recover?Aim, London's junior stock market, has become less appealing to investors amid scandals and an upcoming inheritance tax blow next April. Will it make a turnaround?
-
Investors remain calm as the Middle East war unfoldsConflict in the Middle East has failed to shake oil or stock markets. Can the peace hold?
-
London's new private stock market Pisces 'faces three big problems'Opinion The Pisces exchange may fill a gap in the market, but it won’t address the real problem, says Matthew Lynn
-
Spectra Systems: a 'boffin-led' tech stock with business acumenOpinion Patient investors will get paid well as they wait for success from Spectra Systems, a promising Aim stock, says Jamie Ward
-
How amateur investors could rescue UK stocksPrivate investors must be the beneficiaries of a stock market recovery, says Bruce Packard – not brokers and fund managers
-
The British railway industry is in rude health – here's why investors should jump aboardThe railway industry has bounced back from the devastating impact of the pandemic and is entering a new phase of development – and profitability
-
A cyclical case for UK stocksOpinion Depressed margins and relatively low valuations mean the UK market could rally strongly as conditions improve, says Cris Sholto Heaton.
